Diaceutics PLC Diaceutics to attend Stifel Conference in NYC
30 Novembre 2023 - 8:00AM
RNS Non-Regulatory
TIDMDXRX
Diaceutics PLC
30 November 2023
Diaceutics to attend Stifel and LSE 'Best of British' Conference
in NYC
Belfast and London, 30 November 2023 - Diaceutics PLC (AIM:
DXRX), a leading technology and solutions provider to the
pharmaceutical and biotech industry, announces that management will
attend the Stifel 5(th) Annual 'Best of British' Discovery
Conference at the London Stock Exchange's NYC offices on 13
December 2023.
Enquiries:
Diaceutics PLC
Peter Keeling, Chief Executive Officer Tel: +44 (0)28 9040
6500
Ryan Keeling, Chief Executive Officer investorrelations@diaceutics.com
Designate
Nick Roberts, Chief Financial Officer
Stifel Nicolaus Europe Limited (Nomad Tel: +44 (0)20 7710 7600
& Broker)
Ben Maddison
Nick Harland
Kate Hanshaw
Alma Strategic Communications Tel: +44(0)20 3405 0205
Caroline Forde diaceutics@almastrategic.com
Matthew Young
Kinvara Verdon
About Diaceutics
At Diaceutics we believe that every patient should get the
opportunity to receive the right test and the right therapy to
positively impact their disease outcome.
We provide the world's leading pharma and biotech companies with
an end-to-end commercialisation solution for precision medicines
through data analytics, scientific and advisory services enabled by
our platform DXRX - The Diagnostics Network (R)
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAEAEFPAELDFAA
(END) Dow Jones Newswires
November 30, 2023 02:00 ET (07:00 GMT)
Grafico Azioni Diaceutics (LSE:DXRX)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Diaceutics (LSE:DXRX)
Storico
Da Mag 2023 a Mag 2024